Enzo Biochem Shareholders Elect Directors, Reject Exec Pay

Enzo Biochem (ENZ) has released an update to notify the public and investors about the submission of matters to a vote of security holders.

During the 2023 Annual Meeting, a quorum was established with over 87% of shareholders represented. They elected Steven J. Pully, Bradley L. Radoff, Mary Tagliaferri, M.D., and Kara Cannon to the Board for a term ending at the 2024 Annual Meeting. However, the compensation for the Company’s named executive officers was not approved in a nonbinding advisory vote. Lastly, the shareholders ratified the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for the fiscal year ending July 31, 2024.

For further insights into ENZ corporate activity, check out TipRanks’ Insiders Trading Activity page.

For a comprehensive understanding of the announcement, you can read the full document here.